Status:

WITHDRAWN

Quantifying tACS-driven Improvement of Working Memory in Depression

Lead Sponsor:

University of Minnesota

Conditions:

Depression

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

TACS is an emergent method of non-invasive neuromodulation which can engage frequency-specific brain oscillations. It is increasingly recognized that neural oscillations play a system-organizing role ...

Eligibility Criteria

Inclusion

  • Age between 18 and 60 years old.
  • Stated willingness to participate and comply with all study procedures.
  • Stated availability for the duration of the study.
  • Meet criteria for Major Depressive Disorder.
  • Agreement to adhere to lifestyle considerations throughout study duration.
  • No conflict of interest with the Department of Biomedical Engineering at the University of Minnesota.
  • Confident level of English language.

Exclusion

  • History or evidence of chronic neurological disorder (e.g., history of seizures, epilepsy, unexplained episodes of loss of consciousness, serious brain injury, severe or frequent headaches)
  • Metal or electric implant in the head, neck or chest area.
  • Implanted pacemakers or other electrically, magnetically, ir mechanically activated implant
  • Vascular clips or other electrically sensitive support systems in the brain
  • Serious health conditions (e.g., congestive heart failure pulmonary obstructive chronic disease, active neoplasia)
  • History of head injuries.
  • Pregnancy or breast-feeding.
  • Significant damage of skin at sites of stimulation or other skin concerns, such as dermatitis, psoriasis, or eczema
  • Alcohol or drug addiction.
  • Any legal reason why the candidate cannot participate.
  • Concurrent enrollment in another scientific or clinical study.
  • Estimated IQ is below 70, defined by the WTAR.
  • Active suicidality or other non-controlled neuropsychiatric illness. Active suicidality will be excluded based on a C-SSRS score of 3 or above in the last 6 months. Severe depression is defined as a PHQ-9 score above 20, which will also be excluded.
  • A lifetime suicide attempt.

Key Trial Info

Start Date :

September 5 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 16 2024

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT06110715

Start Date

September 5 2023

End Date

August 16 2024

Last Update

September 23 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.